Scientific programme - Global Congress on Prostate and Bladder Cancer

(Preliminary)
scientific programme

PROSCA on-demand

Watch presentations on prostate cancer from Saturday 10 October 2020 onwards.

Registered delegates will receive an email with the link to the presentations.

PROSCA live broadcast

14 October 2020
19:00-22:00
Moderator: Bertrand Tombal

Watch the highlights of the presentations and learn more on PCa with live case discussions and debates.

BLADDR on-demand

Watch presentations on bladder cancer from Saturday 10 October 2020 onwards.

Registered delegates will receive an email with the link to the presentations.

BLADDR live broadcast

15 October 2020
19:00-22:00
Moderator: tbc

Watch the highlights of the presentations and learn more on BCa with live case discussions and debates.

PROSCA 2020 On-demand presentations

From Saturday 10 October 2020 onwards

Session 1
Controversies in localised prostate cancer and biochemical recurrence
The role of MRI in active surveillance
 
Debate: Intermediate-risk prostate cancer: patients do care if QoL is fair
Session 2
Advanced prostate cancer
Treatment advances in mHSPC
The current landscape of nmCRPC
Immunotherapy for advanced prostate cancer: progress and new hopes
Session 3
What’s the role of novel imaging in daily clinical practice?
PSMA-PET: does it make a difference for patients at high-risk for de novo N1 disease?
MRI as a community-based screening test for prostate cancer
Session 4
Genetic testing in practice

 

Genetic testing for prostate cancer: are you ready?

PARP inhibitors: which patients will benefit?

PROSCA 2020 Live broadcast

Wednesday 14 October 2020

19:00 – 22:00 (CEST)

Moderator: Bertrand Tombal

 

19:00
Welcome
19:10
Controversies in localised prostate cancer and biochemical recurrence

Key messages

  • The role of MRI in active surveillance
  • Intermediate-risk prostate cancer: patients do care if QoL is fair
 

Voting & case discussion

Q&A

Summary

19:45
Short break
19:50
Advanced prostate cancer

Key messages

  • Treatment advances in mHSPC
  • The current landscape of nmCRPC
  • Immunotherapy for advanced prostate cancer: progress and new hopes
 

Voting & case discussion

Q&A

Summary

20:25
Best posters
20:30
Break
20:40
What’s the role of novel imaging in daily clinical practice?

Key messages

  • PSMA-PET: does it make a difference for patients at high-risk for de novo N1 disease?
  • MRI as a community-based screening test for prostate cancer
 

Voting & case discussion

Q&A

Summary

21:15
Short break
21:20
Genetic testing in practice

Key messages

  • Genetic testing for prostate cancer: are you ready?
  • PARP inhibitors: which patients will benefit?
 

Voting & case discussion

Q&A

Summary

21:55
Wrap up

BLADDR 2020 On-demand presentations

From Saturday 10 October 2020 onwards

Session 1
New options in NMIBC
Intravesical alternatives to BCG
BCG-refractory NMIBC: what now?
 
Prognostic markers: role in follow-up of patient with NMIBC
Session 2
MIBC
Neoadjuvant and adjuvant therapy: what did we learn in 2020 and what can we expect in the near future?
Variant histologies: what’s new?
Robotic intracorporeal urinary diversion: does it pay off?

Advances in RT: focus on hypofractionation
RT + IO: a golden combination?
Session 3
Advanced UCa
Optimising treatment for advanced UCa: combination, maintenance or sequencing?

Metastatic UCa: a glimpse of the near future

cN+ M0 BCa: curative or palliative treatment plan?

BLADDR 2020 Live broadcast

Thursday 15 October 2020

19:00 – 22:00 (CEST)

Moderator: tbc

 

19:00
Welcome
19:10
New options in NMIBC

Key messages

  • Intravesical alternatives to BCG
  • BCG-refractory NMIBC: what now?
  • Prognostic markers: role in follow-up of patient with NMIBC
 

Voting & case discussion

Q&A

Summary

19:55
Break
20:05
MIBC

Key messages

  • Neoadjuvant and adjuvant therapy: what did we learn in 2020 and what can we expect in the near future?
  • Variant histologies: what’s new?
  • Robotic intracorporeal urinary diversion: does it pay off?
  • Advances in RT: focus on hypofractionation
  • RT + IO: a golden combination?
 

Voting & case discussion

Q&A

Summary

20:50
Best posters
20:55
Break
21:05
Advanced UCa

Key messages

  • Optimising treatment for advanced UCa: combination, maintenance or sequencing?
  • Metastatic UCa: a glimpse of the near future
  • cN+ M0 BCa: curative or palliative treatment plan?
 

Voting & case discussion

Q&A

Summary

21:55
Wrap up
Legend:
Lecture
Debate/ panel discussion
Q&A

Mirrors of Medicine

Organised by
ISSECAM

Congress management by
e-HIMS